The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients
ConditionDiabetes Mellitus Type 2
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age35-59
SponsorIndonesia University
About this trial
The goal of this clinical trial is to learn if propolis administration works to change the level of Low Density Lipoprotein (LDL) and High Density Lipoprotein cholesterol (HDL) in diabetic type 2 patients.
The main questions it aims to answer are:
\- Is giving 1 drops/ 10kg/ times, twice daily for 8 weeks will change the level of LDL and HDL level in diabetic type 2 patients compared to placebo? Researchers will compare propolis to a placebo (a look-alike substance that contains no drug) to see if propolis works to change LDL and HDL cholesterol level.
Participants will:
* Take propolis or a placebo, 2 times daily with given dose (1 drops/10 kg/times) every day for 2 months * Visit the sub-district health centre once every 2 weeks for checkups * Get their blood checked before and after intervention
Eligibility criteria
Qualifiers
Controlled Diabetes Mellitus type 2 with HbA1c <7.5%
BMI 23-35 kg/m2
On anti-cholesterol therapy
Disqualifiers
Using injection therapy (insulin or GLP-1 RA)
History of bees product allergy
Active smoker
Consuming alcohol
Trial design
Treatments tested in this trial
- Propolis drops
- Placebo
Treatment groups
64 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov